BG
DNTH icon

Bollard Group’s Dianthus Therapeutics DNTH Stock Holding History

Bollard Group’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,750
Closed -$220K – 434
2020
Q4 		$220K Hold
1,750
– – 0.01% 196
2020
Q3 		$190K Hold
1,750
– – 0.01% 196
2020
Q2 		$210K Hold
1,750
– – 0.01% 183
2020
Q1 		$176K Hold
1,750
– – 0.01% 144
2019
Q4 		$424K Hold
1,750
– – 0.01% 138
2019
Q3 		$287K Sell
1,750
-125
-7% -$23.7K 0.01% 147
2019
Q2 		$442K Hold
1,875
– – 0.02% 151
2019
Q1 		$494K Hold
1,875
– – 0.02% 147
2018
Q4 		$171K Hold
1,875
– – 0.01% 172
2018
Q3 		$360K Buy
+1,875
New +$395K 0.01% 155

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return